Journal of Neuroscience, Vol 12, 3427-3434, Copyright © 1992 by Society for Neuroscience
Binding and retrograde transport of leukemia inhibitory factor by the sensory nervous system
IA Hendry, M Murphy, DJ Hilton, NA Nicola and PF Bartlett
John Curtin School of Medical Research, Australian National University, Canberra A.C.T.
Leukemia inhibitory factor (LIF), a peptide growth factor with multiple
activities, has recently been shown to support the generation and survival
of sensory neurons in cultures of mouse neural crest and dorsal root
ganglia (DRG). We have conducted binding experiments with 125I-LIF on
cultures of DRG to determine the receptor distribution for LIF on these
cells and found that at least 60% of the sensory neurons in the cultures
bound 125I-LIF, all of which could be eliminated by the addition of
unlabeled LIF. The other cells in the culture, which morphologically
appeared to be Schwann cells, did not bind appreciable quantities of
125I-LIF. In order to investigate whether LIF is retrogradely transported
to sensory neurons in vivo, 125I-LIF was injected into the footpads and
gastrocnemius muscles of newborn and adult mice, following sciatic nerve
ligation. Radioactivity accumulated in the distal portion of the sciatic
nerve, indicating retrograde transport of LIF. Subsequent experiments on
mice with unligated sciatic nerves showed that 125I-LIF is specifically
transported into the sensory neurons of the DRG. There was no apparent
transport of 125I-LIF into motor neurons in the spinal cord. These
experiments demonstrate that LIF can specifically bind to and be
transported by sensory neurons and further support the idea that LIF acts
as a target-derived neurotrophic factor, analogous to NGF.